A Message from our Board Chair, Ann Marie Vaughan and President & CEO, John M. Rafferty

As Ontario Genomics marks its 25th year, we celebrate our organization’s role in helping fund cutting-edge science projects that are producing homegrown solutions to some of humanity’s biggest problems.

In the pages ahead, you’ll see how we’re backing real winners in precision healthcare, biotech SMEs, food biomanufacturing, environmental testing and waste upcycling. Looking into the future of Ontario’s workforce, we also ensure Ontario’s young people are informed and inspired about all the exciting opportunities biotechnology is creating, and how they can be a part of it.

Now, more than ever, Ontario Genomics is focused on getting innovative research out of the lab and into the real world for everyone to benefit from. While uncertainty is in the air, so is the opportunity for making positive fundamental changes to the way things are done in healthcare, food and agriculture and in cleantech.

This report features several inspiring examples of how our exceptional team nurtures ideas into reality. We hope you’re as motivated by it as we are!

  • BioCreate is our best-in-class accelerator that is thriving just a couple of years into the program with our stellar start-ups in the health, food and agriculture, and cleantech sectors already achieving incredible metrics like $50.8 million in funding, creating/maintaining 75 jobs and earning $13.1 million in sales and revenue.
  • We’re leading and co-leading six projects in the Canadian Precision Health Initiative (CPHI) which is building the country’s largest collection of human genomic data with the goal of representing Canada’s diverse population so that everyone can benefit from personalized medicine.
  • The eDNA Surveillance Initiative is a new way to include Indigenous perspectives in science. One project will help two First Nations communities develop and use new eDNA/eRNA tools for wastewater and ecological monitoring, while the other will track and organize environmental and clinical antimicrobial resistance.
  • We’re also helping more people benefit from health technology with the Canadian Biotechnology Innovation and Commercialization Program (CBIC), where researchers are developing a home testing kit to determine if prostate biopsies are needed, which is way easier for patients and more efficient for doctors. And the Canadian Bioinformatics Hub (CBH) is creating a community to teach researchers how to access, manage and study health and life science data so they can make important discoveries faster.

What if we could is more than a theme, it is a commitment to transforming scientific discovery into practical, market-ready solutions. As Ontario Genomics enters its next 25 years, we will continue to turn this vision into impact for Ontario, Canada and the world.

Ontario Genomics, Board Chair

Ontario Genomics, President & CEO